5

Mavens Biotech

590083 BSE

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

2
  • Company is almost debt free.
  • Stock is trading at 0.91 times its book value

Weaknesses

3
  • Company has low interest coverage ratio.
  • Company has a low return on equity of -11.1% over last 3 years.
  • Contingent liabilities of Rs.3.56 Cr.

Growth Rate

Net Income Growth
82%

Quarterly Results

Particulars Dec 2013Mar 2014Jun 2014Sep 2014Dec 2014Mar 2015Jun 2015Sep 2015Dec 2015Mar 2016Jun 2016Sep 2016Dec 2016
Sales
9.32
7.2
0.25
0.18
0.23
0.4
0.2
0.21
0.22
0.19
0.21
0.35
0.2
Expenses
9.22
7.41
0.19
0.13
0.18
0.24
0.13
0.15
0.13
0.14
0.17
0.32
0.17
Operating Profit
0.1
-0.21
0.06
0.05
0.05
0.16
0.07
0.06
0.09
0.05
0.04
0.03
0.03
OPM %
1.07%
-2.92%
24%
27.78%
21.74%
40%
35%
28.57%
40.91%
26.32%
19.05%
8.57%
15%
Other Income
0.03
0.03
0.03
0.02
0.03
0
0
0
0
0
0
0
0
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
Depreciation
0.05
0.05
0.04
0.04
0.04
0.15
0.04
0.04
0.04
0.04
0.03
0.03
0.03
PBT
0.08
-0.23
0.05
0.03
0.04
0.01
0.03
0.02
0.05
0.01
0.01
0
0
Tax %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—
—
Net Profit
0.08
-0.24
0.04
0.03
0.04
0.01
0.04
0.02
0.05
0.01
0.01
0.01
0.01
EPS in Rs
0.01
-0.02
0
0
0
0
0
0
0
0
0
0
0
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Sales
21.58
47.41
55.99
45.56
45.83
0.82
1.06
0.83
0.96
0.18
0
0
Expenses
20.25
43.78
54.78
44.49
44.89
0.64
0.74
0.56
0.83
0.43
2.22
0.39
Operating Profit
1.33
3.63
1.21
1.07
0.94
0.18
0.32
0.27
0.13
-0.25
-2.22
-0.39
OPM %
6.16%
7.66%
2.16%
2.35%
2.05%
21.95%
30.19%
32.53%
13.54%
-138.89%
—
—
Other Income
0.1
0.1
0.13
0.11
0.09
0.11
0.08
0
1.22
-1.87
-1.22
-0.44
Interest
0
0
0.01
0
0
0
0
0
0
0
0
0
Depreciation
0.47
0.37
0.41
0.37
0.28
0.22
0.28
0.15
0.1
0.07
0.02
0.01
PBT
0.96
3.36
0.92
0.81
0.75
0.07
0.12
0.12
1.25
-2.19
-3.46
-0.84
Tax %
38.54%
2.08%
0%
13.58%
4%
14.29%
0%
33.33%
10.4%
-0.46%
-1.73%
0%
Net Profit
0.59
3.29
0.92
0.7
0.71
0.07
0.13
0.08
1.12
-2.18
-3.4
-0.84
EPS in Rs
0.05
0.3
0.08
0.06
0.06
0.01
0.01
0.01
0.1
-0.2
-0.31
-0.08
Div. Payout %
55.88%
30.06%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Equity Capital
10.99
10.99
10.99
10.99
10.99
10.99
10.99
10.99
10.99
10.99
10.99
10.99
Reserves
3.6
5.73
6.65
7.35
8.05
8.12
8.15
8.23
1.1
-1.07
-4.47
-5.31
Borrowings
0
0
0
0
0
0
0
0
0
0
0
0
Other Liabilities
0.79
1.7
0.41
0.45
0.39
0.3
0.31
0.34
0.32
0.19
1.02
0.29
Total Liabilities
15.38
18.42
18.05
18.79
19.43
19.41
19.45
19.56
12.41
10.11
7.54
5.97
Fixed Assets
5.13
5
5.29
5.24
4.96
4.74
4.37
4.22
4.12
3.95
3.75
3.74
CWIP
0.58
1.24
1.32
1.44
1.44
1.44
1.44
1.44
0
0
0
0
Investments
0.17
0.25
0.25
0.42
0.42
0.42
0.42
0.42
1.67
1.6
1.6
1.6
Other Assets
9.5
11.93
11.19
11.69
12.61
12.81
13.22
13.48
6.62
4.56
2.19
0.63
Total Assets
15.38
18.42
18.05
18.79
19.43
19.41
19.45
19.56
12.41
10.11
7.54
5.97
Figures in ₹ Crores

Cash Flow

Particulars Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Operating
1.16
1.02
0.74
0.42
-0.07
-0.01
-0.11
0.04
-0.1
-0.2
0
-0.04
Investing
-1.21
-0.88
-0.65
-0.51
0.09
0.05
0.08
-0.01
-0.03
0.09
0.02
0.02
Financing
0
0
0
0
0
0
0
0
0
0
0
0
Net Cash Flow
-0.05
0.14
0.09
-0.09
0.02
0.04
-0.03
0.04
-0.13
-0.11
0.02
-0.02
Free Cash Flow
-0.35
0.12
-0.04
-0.03
-0.07
-0.01
-0.11
0.03
-0.1
-0.16
0
-0.04
CFO/OP
109
37
68
45
-3
-6
-19
15
-77
76
0
10
Figures in ₹ Crores

Ratios

Particulars Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Debtor Days
44.48
27.64
23.08
32.53
35.36
2,030
138
83.55
236
1,318
—
—
Inventory Days
120
57.31
21.38
25.65
24.45
—
—
—
543
1,460
0
—
Days Payable
0.41
2.87
1.22
1.59
0.99
—
—
—
0
0
—
—
Cash Conversion Cycle
164
82.07
43.23
56.59
58.82
2,030
138
83.55
778
2,778
—
—
Working Capital Days
146
77.3
41.27
53.68
56.07
3,192
27.55
-65.96
563
3,184
—
—
ROCE %
6.63%
21.46%
5.41%
4.5%
4.01%
0.37%
0.63%
0.63%
7.98%
-2.45%
-27.01%
-6.23%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Mavens Biotech insights

58 extracted metrics + investor summaries across FY09–FY25.

Log in — free

Shareholding Pattern

Public67.96%Promot.32.04%As ofDec 2016

Y-axis zoomed to the data range so small moves stay visible — it does not start at 0%.

Documents

Frequently Asked Questions about Mavens Biotech

What does Mavens Biotech Ltd do?
Mavens Biotech Ltd. engages in agricultural biotechnology business in India. The company propagates plants by tissue culture and introduces new breeds of plant material.
Where is Mavens Biotech Ltd (590083) listed?
Mavens Biotech Ltd trades under code 590083 on the BSE.
Which sector does Mavens Biotech Ltd belong to?
Mavens Biotech Ltd is classified under the Healthcare sector, in the Pharmaceuticals & Biotechnology industry.

Company Information

Mavens Biotech Ltd. engages in agricultural biotechnology business in India. The company propagates plants by tissue culture and introduces new breeds of plant material.

Website mavensbiotech.com
Listed 2008-05-06
Face Value ₹ 1

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/590083.md for Mavens Biotech Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Healthcare → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List